Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Cir Cir ; 85(6): 478-484, 2017.
Article in Spanish | MEDLINE | ID: mdl-28110900

ABSTRACT

BACKGROUND: Retinopathy of prematurity (ROP) is an eye disease caused by an alteration in retinal vasculogenesis that may lead to partial or complete vision loss with a harmful impact in terms of neurodevelopment. The purpose of the present study was to determine the neurodevelopment in patients with type i retinopathy of prematurity treated with intravitreal bevacizumab. MATERIAL AND METHODS: Case series. The inclusion criteria were: patients with type I ROP treated with a dose of 0.625mg/0.025ml of intravitreal bevacizumab. Demographic data and comorbidities were documented. Neurodevelopment was evaluated with the screening test of the Bayley Scale of Infant Development (BSID) in all patients between 11 and 28 weeks of age. RESULTS: Seven patients were included in the study. Four patients showed normal neurodevelopment according to the overall scores of the BSID scale. The distribution of high risk for neurodevelopmental delay in the different areas evaluated were as follows: 3 patients presented it in the cognitive area, one in the receptive communication area, one in the expressive area, one in the fine motor skills and 3 patients in the gross motor skills area. CONCLUSIONS: In these case series, the majority of patients treated with intravitreal bevacizumab for ROP showed normal neurodevelopment scores.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Bevacizumab/therapeutic use , Neurodevelopmental Disorders/etiology , Retinopathy of Prematurity/drug therapy , Adult , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/adverse effects , Bevacizumab/administration & dosage , Bevacizumab/adverse effects , Cesarean Section , Female , Follow-Up Studies , Gestational Age , Humans , Hyperbilirubinemia/complications , Infant, Low Birth Weight , Infant, Newborn , Infant, Premature , Infant, Very Low Birth Weight , Intravitreal Injections , Male , Maternal Age , Neurodevelopmental Disorders/chemically induced , Neurodevelopmental Disorders/epidemiology , Neurodevelopmental Disorders/prevention & control , Pregnancy , Pregnancy Complications/epidemiology , Retinopathy of Prematurity/complications , Treatment Outcome , Young Adult
2.
Cir Cir ; 84(6): 454-458, 2016.
Article in Spanish | MEDLINE | ID: mdl-27133521

ABSTRACT

BACKGROUND: Autologous internal limiting membrane transplantation has allowed some cases of macular holes refractory to conventional surgery techniques to be treated. The purpose of this study is to describe the anatomical and functional outcomes of a modification of this technique in a case series of naïve macular hole patients. MATERIAL AND METHODS: A consecutive case series study was performed on patients with naïve macular holes with a diameter greater than 600 µ. Best corrected visual acuity, clinical features of the macular area, and optical coherence tomography were recorded before the operation and at the end of follow-up in all patients studied. All patients underwent 23 Ga core vitrectomy, posterior hyaloid separation, and brilliant-blue assisted internal limiting membrane peeling. A small piece of the internal limiting membrane was peeled off to make a free flap, and this was trasplanted and placed inside the macular hole under perfluorocarbon liquids. Air-fluid exchange was performed and SF6 gas was injected at a non-expansile concentration. RESULTS: The study included 5 eyes of 5 patients who underwent internal limiting membrane autograft. The mean age was 50.6 (SD 12.3) years. Four of the 5 cases had macular hole closure. The case where there was no closure of the macular hole was secondary to trauma. There was an improvement in visual acuity in all patients where the closing of the macular hole was achieved at the end of follow-up. CONCLUSIONS: In this cases series of macular hole patients, the autologous internal limiting membrane transplantation was associated with an anatomical closure of the macular hole and functional improvement in most of the patients studied.


Subject(s)
Free Tissue Flaps , Membranes/transplantation , Retinal Perforations/surgery , Adult , Astrocytes/transplantation , Ependymoglial Cells/transplantation , Female , Humans , Male , Middle Aged , Sulfur Hexafluoride , Tomography, Optical Coherence , Transplantation, Autologous , Treatment Outcome , Visual Acuity , Vitrectomy
3.
Cir Cir ; 84(4): 309-12, 2016.
Article in Spanish | MEDLINE | ID: mdl-26826892

ABSTRACT

BACKGROUND: Central serous choroidopathy is a macular disease, usually with a self-limited and benign course, and predominantly affects male patients between 20 and 45 years old. CLINICAL CASE: A 68 year-old female patient complained of decreased visual acuity of her right eye of approximately 3 weeks of onset. Best corrected visual acuity in her right eye was 20/100. Fundus examination revealed a macular serous detachment involving its centre, as well as the presence of multiple calcified drusen. Fluorescein angiography showed late parafoveal leakage in a "smokestack" pattern in the right macular area. Optical coherence tomography showed a dome-shape macular detachment, also in the right eye. The patient was observed every 2 weeks and spontaneous resolution of the macular detachment was seen a month later. Based on these clinical features, a diagnosis was made of central serous choroidopathy of atypical presentation. CONCLUSIONS: Atypical presentation cases of serous central choroidopathy might be seen occasionally. Hence, it is an important differential diagnosis of age related macular degeneration in patients older than 60 years.


Subject(s)
Central Serous Chorioretinopathy/diagnosis , Retinal Detachment/etiology , Aged , Calcinosis/etiology , Central Serous Chorioretinopathy/complications , Female , Fluorescein Angiography , Humans , Retinal Drusen/etiology , Tomography, Optical Coherence , Visual Acuity
4.
Case Rep Ophthalmol ; 7(3): 251-255, 2016.
Article in English | MEDLINE | ID: mdl-28101042

ABSTRACT

During a pars plana vitrectomy, an unplanned retinotomy in the raphe was performed in a 55-year-old female patient with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Since diathermy and laser therapy were not available at that moment, it was decided to peel off a small graft of the internal limiting membrane adjacent to the retinotomy site which had been previously stained with Brilliant Blue G. The graft was displaced under perfluorocarbon fluids and placed inside the retinotomy. Three weeks after surgery, the apparent closure of the retinotomy was observed clinically.

5.
Cir Cir ; 84(2): 135-9, 2016.
Article in Spanish | MEDLINE | ID: mdl-26242824

ABSTRACT

BACKGROUND: Acute posterior multifocal placoid pigment epitheliopathy is an unusual, self-limited, inflammatory disease that affects the choriocapillaris, and external retinal layers. CLINICAL CASE: A 26 year-old male patient complained of decreased visual acuity, as well as photopsia in both eyes for the past three days. Best corrected visual acuity was 20/200 in the right eye and 20/80 in the left eye. There was no anterior chamber inflammation or vitritis in either eye. There were plaque-like, cream-coloured sub-retinal lesions with ill-defined borders in the posterior pole of both eyes. Fluorescein angiography showed hypofluorescent lesions in early phases that corresponded to the lesions seen in the clinical examination. These lesions were hyperfluorescent in later phases of the angiography. Based on the clinical and angiographic findings, an acute posterior multifocal placoid pigment epitheliopathy diagnosis was made. CONCLUSIONS: Acute posterior multifocal placoid pigment epitheliopathy is an inflammatory condition of unknown origin that is part of the differential diagnosis of placoid retinal diseases.


Subject(s)
Eye Diseases/diagnostic imaging , Pigment Epithelium of Eye , Acute Disease , Adult , Fluorescein Angiography , Humans , Male
6.
Cir Cir ; 83(2): 100-6, 2015.
Article in Spanish | MEDLINE | ID: mdl-25986974

ABSTRACT

BACKGROUND: Pro-inflammatory cytokines play an important role in diabetic retinopathy. There is conflicting evidence about their serum elevation in this condition and that they also may be possible serum inflammatory biomarkers of diabetic retinopathy. OBJECTIVE: To evaluate the presence of serum pro-inflammatory cytokines and acute phase reactants in the serum of patients with and without diabetic retinopathy. MATERIAL AND METHODS: Comparative case series with 36 patients divided into three groups were included: 12 patients with diabetes mellitus and diabetic retinopathy (group 1), 12 diabetic patients without diabetic retinopathy (group 2), and 12 healthy patients as a control group. Serum levels of the following pro-inflammatory cytokines were measured in all patients: TNF-α, IL-1ß and IL-6. Pro-inflammatory biomarkers measurements were also performed, such as erythrocyte sedimentation rate and C-reactive protein. RESULTS: The levels of TNF-α and IL-6 were higher in group 1 (TNF-α: 19.4 ± 10.9 pg/ml, IL-6: 5.75 ± 7 pg/ml) compared to the other two groups, although the difference was statistically significant only in the case of TNF-α (group 1: 19.4 ± 10.9 pg/ml, group 2: 14 ± 4.3 pg/ml and control: 8.49 ± 3.69 pg/ml, p = 0.001). There were no differences among pro-inflammatory biomarkers such as erythrocyte sedimentation rate and C reactive protein. among the three groups (p > 0.05). CONCLUSIONS: Pro-- inflammatory serum cytokine levels were higher in the diabetes mellitus with diabetic retinopathy group. Larger studies are warranted to establish the real impact of this finding.


Subject(s)
Acute-Phase Proteins/analysis , Diabetic Retinopathy/blood , Interleukin-1beta/blood , Interleukin-6/blood , Tumor Necrosis Factor-alpha/blood , Biomarkers/blood , Female , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...